Search results for: 'transform 2023'

Healthcare during the COVID-19 pandemic has undeniably seen some of its most significant changes. The growth of digital health was a silver lining, and enterprise IT solution providers and telehealth vendors saw tremendous growth during this time. They will continue to see the same in the coming years. Digital health continued to have a winning str...

27 Nov 2024  |  Global  |  Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

Gen AI-based Solutions are Driving Transformational Growth across the Payer and Provider Ecosystem as Organizations Move from Identification to Implementation

Infographics

×

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journey. Gen AI seamlessly syncs with existing tools/IT ...

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

28 Jun 2024  |  Global  |  Market Research

Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029

A Steady Increase in Laboratory Budgets in Academia is Driving Innovation

Infographics

×

This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...

The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interventional and image-guided therapy; physiology and f...

The healthcare cloud market is undergoing rapid transformation, driven by strategic imperatives that will redefine industry dynamics in 2026. Frost & Sullivan’s analysis identifies 10 critical shifts shaping this evolution, anchored in technological innovation, regulatory compliance, and operational resilience. Cloud adoption is no longer limited t...

30 Oct 2024  |  Global  |  Market Research

Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Integrated and Scalable Core Lab Solutions Driving Transformational Growth

Infographics

×

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...

Healthcare as an industry is entering a phase of rapid transformation. Institutions across the stakeholder spectrum including health insurers, providers, and therapeutic developers face the proposition of adapt or collapse. The health insurance industry particularly is evaluating all aspects of its business models, policy holder engagement, and pla...

This study focuses on the global electrophysiology (EP) ablation devices market. It analyzes the market for catheter-based ablation technologies used primarily to treat cardiac arrhythmias (especially atrial fibrillation), including radiofrequency (RF), cryoablation, pulse field ablation (PFA), and emerging modalities.The global EP ablation devices...